2-47805601-ATTTTT-ATTTTTT
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_000179.3(MSH6):c.3557-4dupT variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.148 in 147,526 control chromosomes in the GnomAD database, including 1,781 homozygotes. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★★).
Frequency
Consequence
NM_000179.3 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.148 AC: 21845AN: 147468Hom.: 1779 Cov.: 28
GnomAD4 exome Data not reliable, filtered out with message: InbreedingCoeff AF: 0.268 AC: 284923AN: 1061714Hom.: 1504 Cov.: 14 AF XY: 0.268 AC XY: 142604AN XY: 531538
GnomAD4 genome AF: 0.148 AC: 21852AN: 147526Hom.: 1781 Cov.: 28 AF XY: 0.148 AC XY: 10670AN XY: 71868
ClinVar
Submissions by phenotype
not specified Benign:8
- -
This variant is classified as Benign based on local population frequency. This variant was detected in 25% of patients studied by a panel of primary immunodeficiencies. Number of patients: 24. Only high quality variants are reported. -
- -
- -
Variant summary: MSH6 c.3557-4dupT alters a non-conserved nucleotide located close to a canonical splice site and therefore could affect mRNA splicing, leading to a significantly altered protein sequence. 5/5 computational tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 0.15 in 27938 control chromosomes in the gnomAD database, including 314 homozygotes. The observed variant frequency is approximately 1075 fold of the estimated maximal expected allele frequency for a pathogenic variant in MSH6 causing Lynch Syndrome phenotype (0.00014), strongly suggesting that the variant is benign. c.3557-4dupT has been reported in the literature in multiple affected individuals and also, a large number of controls and has been described as a polymorphism (Wasielewski_2010, Vahteristo_2005, Charames_2000). To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. A ClinVar submission from a clinical diagnostic laboratory (evaluation after 2014) cites the variant as benign. Based on the evidence outlined above, the variant was classified as benign. -
- -
- -
- -
Hereditary cancer-predisposing syndrome Benign:3
- -
- -
This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Lynch syndrome 5 Benign:1
- -
Endometrial carcinoma;C1833477:Lynch syndrome 5;C5436807:Mismatch repair cancer syndrome 3 Benign:1
- -
Lynch syndrome Benign:1
MAF >1% -
not provided Benign:1
- -
Familial cancer of breast Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at